Plavix Unione Europea - italiano - EMA (European Medicines Agency)

plavix

sanofi winthrop industrie - clopidogrel idrogeno solfato - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - agenti antitrombotici - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. prevenzione di atherothrombotic e di eventi tromboembolici in fibrillazione fibrillationin pazienti adulti con fibrillazione atriale che hanno almeno un fattore di rischio per eventi vascolari, non sono adatti per il trattamento con vitamina-k antagonisti e che hanno un basso rischio di sanguinamento, il clopidogrel è indicato, in associazione con asa per la prevenzione di atherothrombotic ed eventi tromboembolici, tra cui ictus.

DuoPlavin 75/100 mg compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

duoplavin 75/100 mg compresse rivestite con film

sanofi-aventis (suisse) sa - clopidogrelum, acidum acetylsalicylicum - compresse rivestite con film - clopidogrelum 75 mg ut clopidogreli hydrogenosulfas 97.875 mg, acidum acetylsalicylicum 100 mg, maydis amylum, mannitolum, macrogolum 6000, cellulosum microcristallinum, hydroxypropylcellulosum, ricini oleum hydrogenatum, acidum stearicum, silica colloidalis anhydrica, pellicule: lactosum monohydricum 8 mg, hypromellosum, triacetinum, cera carnauba, e 171, e 172 (rubrum), pro compresso obducto. - inibitore dell'aggregazione thrombocyte - synthetika

Cardioral capsula molle Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

cardioral capsula molle

ibsa institut biochimique sa - acidum acetylsalicylicum - capsula molle - acidum acetylsalicylicum 75 mg, omega-3 acidorum triglycerida, amylum pregelificatum, acidum citricum, cera flava, cocois oleum hydrogenatum, palmae oleum, materiale di capsula: gelatina, sorbitolum liquidum partim deshydricum corresp. sorbitolum max. 44.60 mg, glycerolum, maydis amylum pro capsula. - inibitore dell 'aggregazione dei trombociti - synthetika

Aspirin Compresse Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspirin compresse

bayer (schweiz) ag - acidum acetylsalicylicum - compresse - acido acetylsalicylicum 500 mg, excipiens pro compresso. - analgesico, antipyretikum - synthetika

Alcacyl Compresse Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

alcacyl compresse

hänseler ag - acidum acetylsalicylicum - compresse - carbasalatum calcicum 528 mg corrisp. acido acetylsalicylicum 415 mg, excipiens pro compresso. - analgesico, antipyretikum - synthetika

Aspégic 100 Pulver in Beutel Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspégic 100 pulver in beutel

opella healthcare switzerland ag - acidum acetylsalicylicum - pulver in beutel - dl-lysini acetylsalicylas 180 mg corrisp. acido acetylsalicylicum 100 mg, sono, excipiens in polvere per la carta. - analgesico, antipyretikum - synthetika

Aspégic Mite Pulver in Beutel Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspégic mite pulver in beutel

opella healthcare switzerland ag - acidum acetylsalicylicum - pulver in beutel - dl-lysini acetylsalicylas 450 mg corrisp. acido acetylsalicylicum 250 mg, sono, excipiens in polvere per la carta. - analgesico, antipyretikum - synthetika

Aspégic 500 Pulver in Beutel Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspégic 500 pulver in beutel

opella healthcare switzerland ag - acidum acetylsalicylicum - pulver in beutel - dl-lysini acetylsalicylas 900 mg corrisp. acido acetylsalicylicum 500 mg, sono, excipiens in polvere per la carta. - analgesico, antipyretikum - synthetika

Aspégic Forte Pulver in Beutel Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspégic forte pulver in beutel

opella healthcare switzerland ag - acidum acetylsalicylicum - pulver in beutel - dl-lysini acetylsalicylas 1.8 g corrisp. acido acetylsalicylicum 1 g, sono, excipiens in polvere per la carta. - analgesico, antipyretikum - synthetika

Alcacyl 500 Instant-Pulver Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

alcacyl 500 instant-pulver

hänseler ag - acidum acetylsalicylicum - instant-pulver - dl-lysini acetylsalicylas 900 mg corrisp. acido acetylsalicylicum 500 mg, sono, excipiens annuncio granulatum per la carta. - analgesico, antipyretikum - synthetika